# VIVOS INC. (RDGL) · Edgar & Edgarette company card

> Vivos (RDGL) grew revenue 144% in FY2025 to $0 million, operating margin -4629% against a 1.2% median for surgical & medical instruments & apparatus, equity 88.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1449349 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/RDGL) · [JSON](https://www.pops4.com/boards/company/RDGL.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $68,379 |
| Revenue growth, 1 year | 144.3% |
| Revenue growth per year | 46.4% |
| Operating margin | -4628.7% (prior year -9303.0%) |
| Net margin | -4483.9% |
| Operating cash flow | −$2M |
| Capital spending | $103,185 |
| Free cash flow | −$2M |
| Cash | — |
| Long-term debt | — |
| Total assets | $2M |
| Total equity | $2M |
| Equity ÷ assets | 88.9% |
| Return on equity | -184.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -151.92 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$2.1M in FY2025); operating loss: a margin of -4628.7% in FY2025; revenue is hard to predict: its 80% range is ±79%

## Edgarette's reading

Exposure: revenue $68K (FY2025). Experience: revenue up 144.3% on the year, up 46.4% a year over 4 years; operating margin -4628.7%, up from -9303.0%. Soundness: equity 88.9% of assets, return on equity -184.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $43K and $363K next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $37K to $423K. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -4628.7% against a 1.2% median; growth 144.3% against 11.6%.

Range logged 2026-10-06, receipt fe19c0527d0d361f, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 10-Q · filed 2026-11-12 · [filing](https://www.sec.gov/Archives/edgar/data/1449349/000149315226051418/0001493152-26-051418-index.htm)
- DEF 14A · filed 2026-11-09 · [filing](https://www.sec.gov/Archives/edgar/data/1449349/000149315226050741/0001493152-26-050741-index.htm)
- 8-K · filed 2026-11-05 · 3.02 Unregistered Sales of Equity Securities; 5.08 Shareholder Nominations Pursuant to Rule 14a-11; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1449349/000149315226050077/0001493152-26-050077-index.htm)
- 8-K · filed 2026-10-08 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1449349/000149315226046354/0001493152-26-046354-index.htm)
- 8-K · filed 2026-10-05 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1449349/000149315226045780/0001493152-26-045780-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1449349/000149315226037380/0001493152-26-037380-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001449349.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1449349

## Cite

POPS4, Edgar & Edgarette: VIVOS INC. (RDGL) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/RDGL. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

